col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
Columbia Data Analytics: Journal of Health Economics and Outcomes Research
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―24 Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan Akira Yuasa, Hiroyuki Matsuda, Yosuke Fujii, Tendai Mugwagwa, Yuki Kado, Mizuki Yoshida, et al. (+2)
2 [GO] 2025―Feb―24 Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan Akira Yuasa, Hiroyuki Matsuda, Yosuke Fujii, Tendai Mugwagwa, Yuki Kado, Mizuki Yoshida, et al. (+2)
3 [GO] 2024―Aug―08 Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study Katy Gallop, Rebekah Hall, Michael Watt, Daniel Squirrels, Neil Branscombe, Sofie Arnetop, Andrew Lloyd
4 [GO] 2024―Aug―08 Use of Population Weighted Density Index for Coronavirus Spread in the United States Huseyin Yuce, Hannah Stauss, Adrienne Persad
5 [GO] 2024―Jul―24 Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study Katy Gallop, Rebekah Hall, Michael Watt, Daniel Squirrell, Neil Branscombe, Sofie Arnetop, Andrew Lloyd
6 [GO] 2024―Jul―24 Use of Population Weighted Density Index for Coronavirus Spread in the United States Huseyin Yuce, Hannah Stauss, Adrienne Persad
7 [GO] 2024―Apr―19 Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19 Chi Nguyen, Christopher Crowe, Effie Kuti, Bonnie Donato, Rachel Djaraher, Leo Seman, et al. (+4)
8 [GO] 2024―Apr―19 Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19 Chi Nguyen, Christopher L. Crowe, Effie Kuti, Bonnie Donato, Rachel Djaraher, Leo Seman, et al. (+4)
9 [GO] 2023―Feb―23 Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients Jay Koyner, Rachel Mackey, Ning Rosenthal, Leslie Carabuena, J. Patrick Kampf, Paul McPherson, et al. (+3)
10 [GO] 2023―Feb―23 Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients Jay Koyner, Rachel Mackey, Ning Rosenthal, Leslie Carabuena, J. Patrick Kampf, Paul McPherson, et al. (+3)
11 [GO] 2023―Feb―23 Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients Jay L. Koyner, Rachel H. Mackey, Ning A. Rosenthal, Leslie A. Carabuena, J. Patrick Kampf, Paul McPherson, et al. (+3)
12 [GO] 2021―Jun―25 Non-traditional Use of HEOR To Identify Host Response Treatments During a Pandemic Peter J. Mallow, David S. Fedson
13 [GO] 2021―Jun―25 Non-traditional Use of HEOR To Identify Host Response Treatments During a Pandemic Peter J Mallow, David S Fedson
14 [GO] 2021―Mai―11 Determinants of COVID-19 Case Fatality Rate in the US: Spatial Analysis Over One Year of the Pandemic Niranjan Kathe, Rajvi Wani
15 [GO] 2021―Apr―16 The Economic Impact of COVID-19 Treatment at a Hospital-level: Investment and Financial Registers of Brazilian Hospitals Ana Paula Beck da Silva Etges, Ricardo Bertoglio Cardoso, Milena Marcolino, Karen Brasil Ruschel, Ana Paula Coutinho, Ana Paula Coutinho, et al. (+19)
16 [GO] 2020―Okt―07 Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database Peter J. Mallow, Kathy W. Belk, Michael Topmiller, Edmond A. Hooker
 [1] 

16 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec